兆新股份(002256.SZ):匯通正源所持約1.21億股的第二次司法拍賣 因無人出價已流拍
格隆匯10月18日丨兆新股份(002256.SZ)公佈,公司大股東深圳市匯通正源股權投資基金合夥企業(有限合夥)(“匯通正源”)因公證債權文書一案,其持有的公司股份121,427,844股(佔公司總股本的6.45%)已於2021年9月14日10時至2021年9月15日10時進行第一次公開拍賣,因該次拍賣無人競拍,已流拍。2021年10月15日10時至2021年10月16日10時,上述股份在廣東省深圳市中級人民法院(“深圳中院”)京東網司法拍賣平台進行第二次公開拍賣。
根據深圳中院京東網司法拍賣平台頁面顯示,此次司法拍賣因無人出價,已流拍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.